284 related articles for article (PubMed ID: 7932756)
1. Drug-protein interactions. Refined structures of three sulfonamide drug complexes of human carbonic anhydrase I enzyme.
Chakravarty S; Kannan KK
J Mol Biol; 1994 Oct; 243(2):298-309. PubMed ID: 7932756
[TBL] [Abstract][Full Text] [Related]
2. Crystallographic studies of inhibitor binding sites in human carbonic anhydrase II: a pentacoordinated binding of the SCN- ion to the zinc at high pH.
Eriksson AE; Kylsten PM; Jones TA; Liljas A
Proteins; 1988; 4(4):283-93. PubMed ID: 3151020
[TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site region of the human isoform II as compared to the structurally related cyclooxygenase II "selective" inhibitor celecoxib.
Di Fiore A; Pedone C; D'Ambrosio K; Scozzafava A; De Simone G; Supuran CT
Bioorg Med Chem Lett; 2006 Jan; 16(2):437-42. PubMed ID: 16290146
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of carbonic anhydrase from Neisseria gonorrhoeae and its complex with the inhibitor acetazolamide.
Huang S; Xue Y; Sauer-Eriksson E; Chirica L; Lindskog S; Jonsson BH
J Mol Biol; 1998; 283(1):301-10. PubMed ID: 9761692
[TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase inhibitors: X-ray crystallographic studies for the binding of 5-amino-1,3,4-thiadiazole-2-sulfonamide and 5-(4-amino-3-chloro-5-fluorophenylsulfonamido)-1,3,4-thiadiazole-2-sulfonamide to human isoform II.
Menchise V; De Simone G; Di Fiore A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2006 Dec; 16(24):6204-8. PubMed ID: 17000110
[TBL] [Abstract][Full Text] [Related]
6. Crystal structure of human carbonic anhydrase XIII and its complex with the inhibitor acetazolamide.
Di Fiore A; Monti SM; Hilvo M; Parkkila S; Romano V; Scaloni A; Pedone C; Scozzafava A; Supuran CT; De Simone G
Proteins; 2009 Jan; 74(1):164-75. PubMed ID: 18618712
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors. Zonisamide is an effective inhibitor of the cytosolic isozyme II and mitochondrial isozyme V: solution and X-ray crystallographic studies.
De Simone G; Di Fiore A; Menchise V; Pedone C; Antel J; Casini A; Scozzafava A; Wurl M; Supuran CT
Bioorg Med Chem Lett; 2005 May; 15(9):2315-20. PubMed ID: 15837316
[TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase inhibitors. X-ray crystal studies of the carbonic anhydrase II-trithiocarbonate adduct--an inhibitor mimicking the sulfonamide and urea binding to the enzyme.
Temperini C; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2010 Jan; 20(2):474-8. PubMed ID: 20005709
[TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase inhibitors: X-ray crystallographic structure of the adduct of human isozyme II with a topically acting antiglaucoma sulfonamide.
Abbate F; Casini A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2004 May; 14(9):2357-61. PubMed ID: 15081040
[TBL] [Abstract][Full Text] [Related]
10. Development of potent carbonic anhydrase inhibitors incorporating both sulfonamide and sulfamide groups.
D'Ambrosio K; Smaine FZ; Carta F; De Simone G; Winum JY; Supuran CT
J Med Chem; 2012 Aug; 55(15):6776-83. PubMed ID: 22775345
[TBL] [Abstract][Full Text] [Related]
11. Interactions between carbonic anhydrase and its inhibitors revealed by gel electrophoresis and circular dichroism.
Gianazza E; Sirtori CR; Castiglioni S; Eberini I; Chrambach A; Rondanini A; Vecchio G
Electrophoresis; 2000 May; 21(8):1435-45. PubMed ID: 10832870
[TBL] [Abstract][Full Text] [Related]
12. Conformational variability of different sulfonamide inhibitors with thienyl-acetamido moieties attributes to differential binding in the active site of cytosolic human carbonic anhydrase isoforms.
Biswas S; Aggarwal M; Güzel Ö; Scozzafava A; McKenna R; Supuran CT
Bioorg Med Chem; 2011 Jun; 19(12):3732-8. PubMed ID: 21620713
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase activators: the first X-ray crystallographic study of an adduct of isoform I.
Temperini C; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2006 Oct; 16(19):5152-6. PubMed ID: 16870440
[TBL] [Abstract][Full Text] [Related]
14. Enzyme-substrate interactions. Structure of human carbonic anhydrase I complexed with bicarbonate.
Kumar V; Kannan KK
J Mol Biol; 1994 Aug; 241(2):226-32. PubMed ID: 8057362
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of the complex between human carbonic anhydrase II and the aromatic inhibitor 1,2,4-triazole.
Mangani S; Liljas A
J Mol Biol; 1993 Jul; 232(1):9-14. PubMed ID: 8331673
[TBL] [Abstract][Full Text] [Related]
16. Investigating the specific interactions between carbonic anhydrase and a sulfonamide inhibitor by single-molecule force spectroscopy.
Kamper SG; Porter-Peden L; Blankespoor R; Sinniah K; Zhou D; Abell C; Rayment T
Langmuir; 2007 Dec; 23(25):12561-5. PubMed ID: 17973506
[TBL] [Abstract][Full Text] [Related]
17. Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition.
Weber A; Casini A; Heine A; Kuhn D; Supuran CT; Scozzafava A; Klebe G
J Med Chem; 2004 Jan; 47(3):550-7. PubMed ID: 14736236
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase inhibitors: the X-ray crystal structure of the adduct of N-hydroxysulfamide with isozyme II explains why this new zinc binding function is effective in the design of potent inhibitors.
Temperini C; Winum JY; Montero JL; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2007 May; 17(10):2795-801. PubMed ID: 17346964
[TBL] [Abstract][Full Text] [Related]
19. The coumarin-binding site in carbonic anhydrase accommodates structurally diverse inhibitors: the antiepileptic lacosamide as an example and lead molecule for novel classes of carbonic anhydrase inhibitors.
Temperini C; Innocenti A; Scozzafava A; Parkkila S; Supuran CT
J Med Chem; 2010 Jan; 53(2):850-4. PubMed ID: 20028100
[TBL] [Abstract][Full Text] [Related]
20. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
